Caspofungin shows efficacy in patients with invasive aspergillosis who are immunocompromised

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1258, 2000-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients

By Maschmeyer Georg

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1567-1601

Adis International

Access to resources Recommend Favorite

Caspofungin: A Review of its Use in Oesophageal Candidiasis, Invasive Candidiasis and Invasive Aspergillosis

By Keating G.M. Figgitt D.P.

Drugs, Vol. 63, Iss. 20, 2003-01 ,pp. : 2235-2263

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Voriconazole versus Caspofungin for the Treatment of Invasive Aspergillosis in Spain

By Domínguez-Gil Alfonso

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 197-205

Adis International

Access to resources Recommend Favorite

Liposomal Amphotericin and Caspofungin: Salvage Therapy for Invasive Aspergillosis in Hepatic Failure

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 3, 2008-09 ,pp. : 223-225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients

By Fisher Brian T. Zaoutis Theoklis E.

Pediatric Drugs, Vol. 10, Iss. 5, 2008-01 ,pp. : 281-298

Adis International

Access to resources Recommend Favorite